Medical Devices Startups

SANSHO Co., Ltd. is a Japanese drug-development company creating pharmaceuticals based on cyclic phosphatidic acid (cPA), including 2-carba-cyclic phosphatidic acid candidates in clinical trials for knee osteoarthritis and pulmonary fibrosis. The company conducts research and development to bring these medicines to clinical use.

1 investor

Saol Therapeutics is a clinical-stage pharmaceutical company focused on developing therapies for CNS disorders, pain conditions, and orphan diseases. The company recently divested its commercial assets to concentrate on advancing its pipeline of late-stage clinical programs.

1 investor

Sapala Organics is a contract research and manufacturing organization (CRO/CDMO) specializing in nucleic acid chemistry, oligonucleotide synthesis, and medicinal chemistry for the pharmaceutical industry. Now a subsidiary of Cohance Lifesciences, the company provides drug discovery and development services focused on genetic therapies and complex small molecule synthesis.

1 investor

SaRA is a software platform that automates patient engagement for physical therapy, occupational therapy, orthopedic, and pain management practices through SMS and remote therapeutic monitoring. The platform identifies eligible patients, handles billing and denial management for relevant CPT codes, and enables practitioners to meet reimbursement requirements while improving patient adherence to care plans.

1 investor

Sarcio Inc. is a University of Minnesota Stem Cell Institute spin-out developing regenerative, disease-modifying therapeutics by isolating exosomes from iPSC-derived cartilage tissue to treat osteoarthritis and restore joint function. The company aims to delay or eliminate the need for joint-replacement surgery.

1 investor

Sarnova is a health and safety distributor and services company operating through multiple subsidiaries serving emergency medical services, healthcare facilities, and cardiac emergency preparedness markets. The company owns and operates Bound Tree Medical (EMS supply distributor), Tri-anim Health Services (respiratory and critical care products), Cardio Partners (AED and cardiac emergency services), and Digitech (EMS billing and technology platform).

1 investor

Sayre Therapeutics is a pharmaceutical company operating across India, South Asia, and Southeast Asia that distributes differentiated global drugs and treatments for rare and orphan diseases to emerging markets. The company brings novel medical solutions to patients and clinicians in oncology and rare disease care.

1 investor

SB TEMPUS supports personalized medicine for cancer treatment by integrating medical data and AI. The company offers genetic testing, medical data utilization, and AI applications serving healthcare institutions, pharmaceutical companies, and biotech ventures.

1 investor

South Bay Home Health Care provides durable medical equipment and home health care supplies to patients in Southern California, with a focus on mobility aids, assistive devices, and daily living supplies. The company operates a large showroom and offers home delivery and equipment setup services.

1 investor

Scanwell Health develops smartphone applications that enable patients to perform diagnostic tests at home, starting with an FDA-cleared app for urinary tract infection testing and treatment. The platform targets people seeking faster diagnosis and treatment of acute and chronic conditions without visiting a clinic.

1 investor

SCase Vital is a certified class IIb all-in-one medical device that measures vital signs such as body temperature, blood pressure, pulse, blood oxygen and glucose, records wound photos, and transfers data to clinical information systems. It serves hospitals and home care, supporting doctors and nurses as well as individual patients and their families.

1 investor

Scene provides digital medication adherence programs combining video check-ins and human engagement by nurses and pharmacists to improve patient adherence and health outcomes across health systems and care organizations. The company evolved from emocha, a Johns Hopkins-originated technology that has expanded globally to address medication nonadherence in infectious disease treatment and other conditions.

1 investor

Scewo builds the BRO, an electric wheelchair that can climb stairs and curbs and is designed for indoor and outdoor daily use by people with mobility impairments. The company supports users through the trial, prescription, and insurance financing process in Germany and Switzerland.

1 investor

Schivo is a contract manufacturer specializing in medical device components, sub-assemblies, and assemblies for minimally invasive, robotic-assisted, cardiology, and orthopedic surgery systems. The company serves original equipment manufacturers (OEMs) in the medical device industry through ISO 13485-certified and FDA-registered facilities across multiple continents.

1 investor

Science Care operates a non-transplant tissue banking program that partners with medical researchers and educators, enabling donor contributions for medical research, education, and product development. Founded in 2000, the organization manages donation programs while prioritizing donor dignity, ethical practices, and industry standards.

1 investor

SCIEX develops mass spectrometry and capillary electrophoresis instruments, along with software and integrated workflows, for the precision detection and quantitation of molecules. Its products serve research scientists and clinical laboratories, including in vitro diagnostic applications.

1 investor

Scilex Holding Company (Nasdaq: SCLX) acquires, develops, and commercializes non-opioid pain management products for treating acute and chronic pain. It operates in the pharmaceutical industry, offering topical delivery systems and oral analgesic formulations.

1 investor

Scilife builds an electronic quality management system for regulated industries such as healthcare and life sciences, helping teams automate compliance workflows and advance quality operations beyond minimum standards.

1 investor

SciNeuro develops targeted therapeutics for neurodegenerative and age-related brain diseases by integrating patient genetics, health history, and advanced diagnostic tools. The company collaborates with scientific institutions to create disease-modifying therapies addressing aging populations' neurological challenges.

1 investor

Scinvivo develops Lumante, a catheter-based optical coherence tomography (OCT) imaging platform for real-time, minimally invasive visualization and local staging of bladder cancer during cystoscopy. The system, aimed at urologists, has received FDA Breakthrough Device Designation and is in pre-clinical/clinical development.

1 investor

Sciteline provides digital recruitment technology for clinical research trials, helping researchers access diverse patient populations and accelerate trial enrollment. The platform aims to expand patient access to clinical studies and improve healthcare inclusivity through data-driven matching tools.

1 investor

Aitrasound Medical Group develops and markets radiation-free ultrasound equipment for scoliosis assessment, serving hospitals and clinics globally. The company's Scolioscan system uses 3D imaging technology and has been deployed across Europe, Australia, and Asia.

1 investor

Scopebio develops on-site molecular diagnostic assays for detecting crop pathogens, enabling rapid pathogen identification directly in the field. The company serves agricultural producers and offers custom assay development for emerging threats and niche crops.

1 investor

Scout is a clinical trial services provider that manages logistics, payments, and travel support for clinical research participants, sites, and sponsors. The company has over 30 years of experience simplifying clinical trial operations globally.

1 investor